DOCSLIB.ORG

Chapter 1: Introduction

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

MIAMI UNIVERSITY The Graduate School Certificate for Approving the Dissertation We hereby approve the Dissertation of Kerry A. Lucas Candidate for the Degree: Doctor of Philosophy __________________________________ Director (Dr. John W. Hawes) _________________________________ Reader (Dr. Mike W. Crowder) _________________________________ Reader (Dr. Gary A. Lorigan) _________________________________ Reader (Dr. Chris A. Makaroff) _________________________________ Graduate School Representative (Dr. Alfredo J. Huerta) ABSTRACT VALINE METABOLISM IN ARABIDOPSIS By Kerry A. Lucas Branched-chain amino acids (BCAAs) are essential amino acids, meaning mammals have the inability to synthesize them de novo and must therefore obtain them through dietary intake. They have been well studied in mammalian systems due to their key role in several metabolic and signaling pathways. Plants, on the other hand, have the ability to synthesize and degrade BCAAs, although the metabolism and importance of these amino acids is less well understood. It is known that mutations in the biosynthetic pathway results in herbicide resistant plants, whereas mutations in the degradation pathway result in an array of responses, from resistance to hormones, to embryo lethality. The largest questions concerning BCAA metabolism in plants involve understanding valine and propionyl-CoA metabolic pathways. It is believed they share a common pathway; however, the localization and actual enzymatic reactions remain controversial. In an effort to piece together this pathway, several techniques were employed. NMR spectroscopic results showed the peroxisomal metabolism of exogenous propionate through a pathway similar to valine degradation in the mitochondria. Reverse genetics using several knockout mutants in the valine degradation pathway, as well as measuring mRNA levels under several stress conditions, helped to resolve much of the ambiguity regarding this pathway. Based on the data presented in this dissertation, we are the first to provide evidence for the metabolism of propionyl-CoA by a modified β-oxidation pathway that utilizes both the mitochondria and the peroxisomes to produce acetyl-CoA. In addition, preliminary data are presented regarding the maintenance of BCAA homeostasis and evidence for the stimulation of protein synthesis. VALINE METABOLISM IN ARABIDOPSIS A DISSERTATION Submitted to the Faculty of Miami University in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of Chemistry and Biochemistry by Kerry A. Lucas Miami University Oxford, OH 2008 Dissertation Director: Dr. John W. Hawes Table of Contents Chapter 1: Introduction 1 1.1 Branched-chain Amino Acids 1 1.2 BCAA Metabolism in Mammalian Systems 1 1.2.2 BCAAs and Neurotransmitters 3 1.2.3 BCAAs and the Immune System 4 1.2.4 Metabolic Diseases associated with BCAAs 4 1.2.5 Reactive Intermediates 5 1.2.6 Propionyl-CoA Metabolism 5 1.3 BCAA Metabolism in Higher Plants 7 1.3.1 BCAA Synthesis 7 1.3.2 BCAA Degradation 11 1.3.3 Propionyl-CoA Metabolism in Plants 14 1.4 Sections of the Dissertation 16 1.5 References 17 Chapter 2: Peroxisomal Metabolism of Propionic Acid and Isobutyric Acid in A. thaliana 27 2.1 Summary 28 2.2 Introduction 29 2.3 Experimental Procedures 31 2.3.1 Materials 31 2.3.2 Cell Culture and Seedling Preparation and NMR Spectroscopy Procedure 31 2.3.3 End Point Assay for Quantitation of β-Hydroxyisobutyrate 32 2.3.4 Valine, Isobutyrate, and Propionate Growth Response 33 2.4 Results 33 2.4.1 Genes for a Modified Propionate β-Oxidation Pathway in Plants 33 2.4.2 Metabolism of 2-13C-Propionate in A. thaliana Seedlings and Suspension Cell Cultures 37 2.4.3 Effect of chy1 Mutation on Metabolism of Propionate and Isobutyrate 40 2.4.4 Metabolism of 2-13C-Propionate in Different Plants 43 ii 2.4.5 Metabolism of U-13C-Valine in A. thaliana Seedlings 43 2.4.6 Effects of Exogenous Isobutyrate, Propionate, and Valine on Seedling Growth of Wild-type and chy1-3 A. thaliana Seedlings 45 2.5 Discussion 49 2.6 Acknowledgements 52 2.7 References 53 Chapter 3: Functional Diversity of Mitochondrial β-Hydroxyacyl-CoA Hydrolases in A. thaliana 59 3.1 Summary 60 3.2 Introduction 61 3.3 Experimental Procedures 63 3.3.1 Materials 63 3.3.2 Plant Materials and Growth Conditions 63 3.3.3 T-DNA Insertion Mutations 64 3.3.4 Bioinformatic Analysis 64 3.3.5 Recombinant Hydrolases 64 3.3.6 Enzyme Activity 65 3.3.7 Meausring mRNA Levels 65 3.3.8 Complementation 66 3.3.9 Microscopy 66 3.4 Results and Discussion 67 3.4.1 Sequence Identity of Putative Mitochondrial Hydrolases 67 3.4.2 Activity of Recombinant Hydrolases 71 3.4.3 Mitochondrial CHY mRNA Levels of Seedling Growth and the Effects of Sucrose 72 3.4.4 Effects of Metabolites and Oxidative Stress on Mitochondrial CHY mRNA Levels 77 3.4.5 Effects of T-DNA Insertion Mutations 79 3.5 Conclusion 85 3.6 Acknowledgements 86 3.7 References 87 Chapter 4: Evidence for Propionate and Isobutyrate Metabolism involving Mitochondrial Methylmalonate Semialdehyde Dehydrogenase in A. thaliana Mitochondria 92 iii 4.1 Summary 93 4.2 Introduction 94 4.3 Experimental Procedures 97 4.3.1 Plant Materials and Growth Conditions 97 4.3.2 Measuring mRNA Levels 98 4.4 Results 98 4.4.1 AtMMSDH mRNA levels during germination 98 4.4.2 AtMMSDH Knockout Mutant Affects Seed Viability 100 4.4.3 Knockout Mutants Show Sensitivity to Peroxisomal Metabolites 104 4.5 Discussion 107 4.6 Acknowledgements 111 4.7 References 112 Chapter 5: The Biosynthesis of Leucine and Its Effects on Protein Synthesis in A. thaliana 118 5.1 Summary 119 5.2 Introduction 120 5.3.1 Plant Materials and Growth Conditions 124 5.3.2 NMR Sample Preparation and Procedure 124 5.3.3 Measuring mRNA Levels 125 5.4 Results and Discussion 125 5.4.1 The Effects of Sucrose on Leucine Biosynthesis 125 5.4.2 Stimulation of Protein Synthesis by Leucine 126 5.5 Conclusion 129 5.6 Acknowledgements 131 5.7 References 132 Chapter 6: Conclusion 137 6.1 Understanding Branched-Chain Amino Acids 137 6.2 BCAA Metabolism 137 6.3 Valine Degradation 138 6.4 Valine Metabolism in the Chloroplast 140 6.5 Leucine and Protein Synthesis 142 6.6 Future Directions 142 iv 6.6.1 Model for Valine and Propionyl-CoA Metabolism in Plants 142 6.6.2 Stimulation of Protein Synthesis 143 6.7 References 145 v List of Tables Table 1.1 Genes coding for enzymes of valine degradation. 12 Table 2.1 Genes coding for putative enzymes for catabolism of valine and propionyl-CoA in A. thaliana. 35 Table 3.1 Specific Activity of recombinant hydrolases. 73 Table 4.1 Mitochondrial localization prediction scores and potential cleavage sites for AtMMSDH. 109 vi List of Figures Figure 1.1 Branched-chain amino acid degradation pathways. 2 Figure 1.2 Structures of reactive intermediates in valine catabolism. 6 Figure 1.3 Propionyl-CoA metabolic pathways for mammals, bacteria, and plants. 8 Figure 1.4 BCAA biosynthetic pathway. 10 Figure 1.5 Possible routes for propionyl-CoA metabolism in plants. 15 Figure 2.1 Proposed pathways for metabolism of valine and propionyl-CoA in mitochondria and peroxisomes in plants. 34 Figure 2.2 13C-NMR analysis of metabolites produced from 2-13C-propionate in A. thaliana. 38 Figure 2.3 Time course of β-hydroxypropionate production. 39 Figure 2.4 HMQC analysis of standard β-hydroxypropionate and A. thaliana seedlings with 2- 13C-propionate. 41 Figure 2.5 β-Hydroxyisobutyrate accumulation in wild-type and chy1-3 A. thaliana seedlings. 42 Figure 2.6 Production of β-hydroxypropionate in various plants. 44 Figure 2.7 Pathway for the metabolism of valine to leucine. 46 Figure 2.8 13C NMR analysis of A. thaliana seedlings with U-13C-valine. 47 Figure 2.9 Effect of exogenous valine, isobutyrate and propionate on seedling growth. 48 Figure 3.1 Valine catabolic pathway. 62 Figure 3.2 Sequence comparison of A. thaliana CHY proteins with human HIBYL-CoA hydrolase. 68 Figure 3.3 Mitochondrial CHY mRNA levels during seedling growth. 74 Figure 3.4 Effects of sucrose on mitochondrial CHY mRNA levels. 76 Figure 3.5 Effect of metabolites and oxidative stress on mitochondrial CHY mRNA levels. 78 Figure 3.6 Location of T-DNA insertion sites for each mitochondrial CHY gene. 80 Figure 3.7 Light microscopy of A. thaliana siliques. 81 Figure 3.8 Confocal microscopy of chy4 seeds from a single heterozygous silique. 82 Figure 3.9 Valine resistance of chy5 mutant seedlings. 83 Figure 4.1 Valine degradation pathway in mitochondria and peroxisomes. 96 Figure 4.2 mRNA levels of MMSDH during germination and seedling establishment. 99 Figure 4.3 MMSDH mRNA levels in the presence and absence of sucrose. 101 vii Figure 4.4 MMSDH mRNA levels with GA and 2,4-D. 102 Figure 4.5 Location of T-DNA insertion and confirmation of homozygous knockout. 103 Figure 4.6 Growth development of mmsdh knockout seedlings. 105 Figure 4.7 mmsdh Knockout seedlings grown with valine, isobutyrate, and propionate. 106 Figure 4.8 Sequence alignment of MMSDH from A. thaliana, rice, human, and rat. 108 Figure 5.1 BCAA biosynthesis pathway. 121 Figure 5.2 TOR signaling pathway. 123 Figure 5.3 13C-NMR studies. 127 Figure 5.4 mRNA levels during leucine biosynthesis in response to sucrose. 128 Figure 5.5 GFP response to leucine. 130 Figure 6.1 Final model for valine and propionyl-CoA metabolism in plants. 141 viii Acknowledgements The success of this dissertation would not have been possible without the love and support of several people throughout the last five years.
Recommended publications
  • Abstract DRAYTON, JOSEPHINE BENTLEY

    Abstract DRAYTON, JOSEPHINE BENTLEY

    Abstract DRAYTON, JOSEPHINE BENTLEY. Methylated Medium- and Long-Chain Fatty Acids as Novel Sources of Anaplerotic Carbon for Exercising Mice. (Under the direction of Dr. Jack Odle and Dr. Lin Xi.) We hypothesized that methylated fatty acids (e.g. 2-methylpentanoic acid (2MeP), phytanic acid or pristanic acid) would provide a novel source of anaplerotic carbon and thereby enhance fatty acid oxidation, especially under stressed conditions when tricarboxylic acid (TCA) cycle intermediates are depleted. The optimal dose of 2MeP, hexanoic acid (C6) and pristanic acid for increasing in vitro [1-14C]-oleic acid oxidation in liver or skeletal muscle homogenates from fasted mice was determined using incremental doses of 0, 0.25, 0.5, 0.75, or 1.0 mM. The 0.25 mM amount maximally stimulated liver tissue oxidation of 14 14 14 [1- C]-oleate to CO2 and [ C]-acid soluble products (ASP; P < 0.05). Similar incubations of 0.25 mM 2MeP, C6, palmitate, phytanic acid, or pristanic acid or 0.1 mM malate or propionyl-CoA were conducted with liver or skeletal muscle homogenates from exercised or sedentary mice. In vitro oxidation of [1-14C]-oleic acid in liver homogenates with 2MeP 14 14 increased mitochondrial CO2 accumulation (P <0.05), but no change in [ C]-ASP accumulation as compared to C6 (P > 0.05). Phytanic acid treatment increased [14C]-ASP accumulation in liver tissue as compared to palmitate (P < 0.05). Exercise increased [14C] accumulations (P < 0.05). Results were consistent with our hypothesis that methyl-branched fatty acids (2-MeP, phytanic and pristanic acids) provide a novel source of anaplerotic carbon and thereby stimulate in vitro fatty acid oxidation in liver and skeletal muscle tissues.
  • Acetyl-Coa Synthetase 3 Promotes Bladder Cancer Cell Growth Under Metabolic Stress Jianhao Zhang1, Hongjian Duan1, Zhipeng Feng1,Xinweihan1 and Chaohui Gu2

    Acetyl-Coa Synthetase 3 Promotes Bladder Cancer Cell Growth Under Metabolic Stress Jianhao Zhang1, Hongjian Duan1, Zhipeng Feng1,Xinweihan1 and Chaohui Gu2

    Zhang et al. Oncogenesis (2020) 9:46 https://doi.org/10.1038/s41389-020-0230-3 Oncogenesis ARTICLE Open Access Acetyl-CoA synthetase 3 promotes bladder cancer cell growth under metabolic stress Jianhao Zhang1, Hongjian Duan1, Zhipeng Feng1,XinweiHan1 and Chaohui Gu2 Abstract Cancer cells adapt to nutrient-deprived tumor microenvironment during progression via regulating the level and function of metabolic enzymes. Acetyl-coenzyme A (AcCoA) is a key metabolic intermediate that is crucial for cancer cell metabolism, especially under metabolic stress. It is of special significance to decipher the role acetyl-CoA synthetase short chain family (ACSS) in cancer cells confronting metabolic stress. Here we analyzed the generation of lipogenic AcCoA in bladder cancer cells under metabolic stress and found that in bladder urothelial carcinoma (BLCA) cells, the proportion of lipogenic AcCoA generated from glucose were largely reduced under metabolic stress. Our results revealed that ACSS3 was responsible for lipogenic AcCoA synthesis in BLCA cells under metabolic stress. Interestingly, we found that ACSS3 was required for acetate utilization and histone acetylation. Moreover, our data illustrated that ACSS3 promoted BLCA cell growth. In addition, through analyzing clinical samples, we found that both mRNA and protein levels of ACSS3 were dramatically upregulated in BLCA samples in comparison with adjacent controls and BLCA patients with lower ACSS3 expression were entitled with longer overall survival. Our data revealed an oncogenic role of ACSS3 via regulating AcCoA generation in BLCA and provided a promising target in metabolic pathway for BLCA treatment. 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; Introduction acetyl-CoA synthetase short chain family (ACSS), which In cancer cells, considerable number of metabolic ligates acetate and CoA6.
  • 3-Iodo-Alpha-Methyl-L- Tyrosine

    3-Iodo-Alpha-Methyl-L- Tyrosine

    A Strategyfor the Study of CerebralAmino Acid Transport Using Iodine-123-Labeled Amino Acid Radiopharmaceutical: 3-Iodo-alpha-methyl-L- tyrosine Keiichi Kawai, Yasuhisa Fujibayashi, Hideo Saji, Yoshiharu Yonekura, Junji Konishi, Akiko Kubodera, and Akira Yokoyama Faculty ofPharmaceutical Sciences, Science Universityof Tokyo, Tokyo, Japan and School ofMedicine and Faculty of Pharmaceutical Sciences, Kyolo University, Kyoto, Japan In the present work, a search for radioiodinated tyrosine We examined the brain accumulation of iodine-i 23-iodo-al derivatives for the cerebral tyrosine transport is attempted. pha-methyl-L-tyrosine (123I-L-AMT)in mice and rats. l-L-AMT In the screening process, in vitro accumulation studies in showed high brain accumulation in mice, and in rats; rat brain rat brain slices, measurement ofbrain uptake index (BUI), uptake index exceeded that of 14C-L-tyrosine.The brain up and in vivo mouse biodistribution are followed by the take index and the brain slice studies indicated the affinity of analysis of metabolites. In a preliminary study, the radio l-L-AMT for earner-mediatedand stereoselective active trans iodinated monoiodotyrosine in its L- and D-form (L-MIT port systems, respectively; both operating across the blood and D-MIT) and its noniodinated counterpart (‘4C-L- brain barrier and cell membranes of the brain. The tissue tyrosine) are tested. homogenate analysis revealed that most of the accumulated radioactivity belonged to intact l-L-AMT, an indication of its The initial part of the work provided the basis for a stability. Thus, 1231-L-AMTappears to be a useful radiophar radioiodinated tyrosine derivative to be used for the meas maceutical for the selective measurement of cerebral amino urement of cerebral tyrosine transport.
  • Substrate Specificity of Rat Liver Mitochondrial Carnitine Palmitoyl Transferase I: Evidence Against S-Oxidation of Phytanic Acid in Rat Liver Mitochondria

    Substrate Specificity of Rat Liver Mitochondrial Carnitine Palmitoyl Transferase I: Evidence Against S-Oxidation of Phytanic Acid in Rat Liver Mitochondria

    FEBS 15107 FEBS Letters 359 (1995) 179 183 Substrate specificity of rat liver mitochondrial carnitine palmitoyl transferase I: evidence against s-oxidation of phytanic acid in rat liver mitochondria Harmeet Singh*, Alfred Poulos Department of Chemical Pathology, Women's and Children's Hospital 72 King William Road, North Adelaide, SA 5006, Australia Received 23 December 1994 demonstrated that CPTI activity is reversibly inhibited by Abstract The two branched chain fatty acids pristanic acid malonyl-CoA. Recently, it has been shown that malonyl-CoA (2,6,10,14-tetramethylpentadecanoic acid) and phytanic acid inhibits peroxisomal, microsomal and plasma membrane car- (3,7,11,15-tetramethylhexadecanoic acid) were converted to co- nitine acyl transferases [8,10,13]. Therefore, in order to under- enzyme A thioesters by rat liver mitochondrial outer membranes. However, these branched chain fatty acids could not be converted stand the role of CPTI in fatty acid oxidation, CPTI must be to pristanoyl and phytanoyl carnitines, respectively, by mitochon- separated from other carnitine acyl transferases. In view of the drial outer membranes. As expected, the unbranched long chain difficulties in isolating CPTI in the active state, we decided to fatty acids, stearic acid and palmitic acid, were rapidly converted investigate CPTI activity in highly purified mitochondrial outer to stearoyl and palmitoyl carnitines, respectively, by mitochon- membranes from rat liver. We present evidence that branched drial outer membranes. These observations indicate that the chain fatty acids with ~- or fl-methyl groups are poor substrates branched chain fatty acids could not be transported into mito- for CPTI, suggesting that these branched chain fatty acids chondria.
  • Ataxia with Loss of Purkinje Cells in a Mouse Model for Refsum Disease

    Ataxia with Loss of Purkinje Cells in a Mouse Model for Refsum Disease

    Ataxia with loss of Purkinje cells in a mouse model for Refsum disease Sacha Ferdinandussea,1,2, Anna W. M. Zomerb,1, Jasper C. Komena, Christina E. van den Brinkb, Melissa Thanosa, Frank P. T. Hamersc, Ronald J. A. Wandersa,d, Paul T. van der Saagb, Bwee Tien Poll-Thed, and Pedro Britesa Academic Medical Center, Departments of aClinical Chemistry (Laboratory of Genetic Metabolic Diseases) and dPediatrics, Emma’s Children Hospital, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands; bHubrecht Institute, Royal Netherlands Academy of Arts and Sciences 3584 CT Utrecht, The Netherlands; and cRehabilitation Hospital ‘‘De Hoogstraat’’ Rudolf Magnus Institute of Neuroscience, 3584 CG Utrecht, The Netherlands Edited by P. Borst, The Netherlands Cancer Institute, Amsterdam, The Netherlands, and approved October 3, 2008 (received for review June 23, 2008) Refsum disease is caused by a deficiency of phytanoyl-CoA hy- Clinically, Refsum disease is characterized by cerebellar droxylase (PHYH), the first enzyme of the peroxisomal ␣-oxidation ataxia, polyneuropathy, and progressive retinitis pigmentosa, system, resulting in the accumulation of the branched-chain fatty culminating in blindness, (1, 3). The age of onset of the symptoms acid phytanic acid. The main clinical symptoms are polyneuropathy, can vary from early childhood to the third or fourth decade of cerebellar ataxia, and retinitis pigmentosa. To study the patho- life. No treatment is available for patients with Refsum disease, genesis of Refsum disease, we generated and characterized a Phyh but they benefit from a low phytanic acid diet. Phytanic acid is knockout mouse. We studied the pathological effects of phytanic derived from dietary sources only, specifically from the chloro- acid accumulation in Phyh؊/؊ mice fed a diet supplemented with phyll component phytol.
  • Effect of Leucine on Intestinal Absorption of Tryptophan in Rats

    Effect of Leucine on Intestinal Absorption of Tryptophan in Rats

    Downloaded from https://doi.org/10.1079/BJN19850155 British Journal of Nutrition (1985), 54, 695-703 695 https://www.cambridge.org/core Effect of leucine on intestinal absorption of tryptophan in rats BY CHISAE UMEZAWA, YUKO MAEDA, KANJI HABA, MARIKO SHIN AND KEIJI SANO School of Pharmacy, Kobe-Gakuin University, Nishi-ku, Kobe 673, Japan (Received I7 May 1985 - Accepted 24 June 1985) . IP address: 1. To elucidate the causal relation between leucine and the lowering of hepatic NAD content of rats fed on a leucine-excessive diet (Yamada et aZ. 1979), the effect of leucine on intestinal absorption of tryptophan was 170.106.35.93 investigated. 2. Co-administration of [3H]tryptophan and leucine, with leucine at ten times the level of tryptophan, delayed absorption of L-[side chain 2,3-3H]tryptophan from the digestive tract and incorporation of [3H]tryptophan into portal blood, the liver and a protein fraction of the liver. After 120 min, more than 95% of tryptophan was absorbed whether [3H]tryptophan was administered with or without leucine. , on 3. Co-administration of a mixture of ten essential amino acids, in proportions simulating casein, with 02 Oct 2021 at 04:49:27 [3H]tryptophan markedly delayed absorption of tryptophan from the digestive tract. The addition of supplementary leucine to the amino acid mixture, however, caused no further delay. 4. In rats prefed a leucine-excessive diet for 1 week [3H]tryptophan was absorbed at the same rate as in rats fed on a control diet. 5. The results indicate that competition between tryptophan and leucine for intestinal absorption did not cause lowering of hepatic NAD.
  • Electrochemical Studies of Dl-Leucine, L-Proline and L

    Electrochemical Studies of Dl-Leucine, L-Proline and L

    ELECTROCHEMICAL STUDIES OF DL -LEUCINE, 60 L-PROLINE AND L-TRYPTOPHAN AND THEIR INTERACTION WITH COPPER AND IRON 30 c b A) M. A. Jabbar, R. J. Mannan, S. Salauddin and B. µ a Rashid 0 Department of Chemistry, University of Dhaka, ( Current Dhaka-1000, Bangladesh -30 Introduction -60 In vitro study of the charge transfer reactions coupled -800 -400 0 400 800 with chemical reactions can give important indication of Potential vs. Ag/AgCl (mV) about actual biological processes occurring in human Fig.1. Comparison of the cyclic voltammogram of system. Understanding of such charge-transfer 5.0mM (a) DL -Leucine, (b) Cu-DL -Leucine ion and mechanism will help to determine the effectiveness of (c) [Fe-DL -Leucine] in 0.1M KCl solution at a Pt- nutrition, metabolism and treatment of various biological button electrode. Scan rates 50 mV/s. disorders. In the previous research, the redox behaviour of 40 various amino acids and biochemically important compounds and their charge transfer reaction and their b interaction of metal ions were studied [1,2]. In the present 20 ) a c research, the redox behavior and the charge transfer µΑ kinetics of DL -Leucine, L-Proline and L-Tryptophan in 0 the presence and absence of copper and iron will be investigated. Current ( -20 Experimental A computerized electrochemistry system developed by -40 -800 -400 0 400 800 Advanced Analytics, Virginia, USA, (Model-2040) Potential vs. Ag/AgCl (mV) consisting of three electrodes micro-cell with a saturated Ag/AgCl reference, a Pt-wire auxiliary and a pretreated Fig.2 . Comparison of the cyclic voltammogram of Pt-button working electrode is employed to investigate 5.0mM (a) L-Proline, (b) Cu-L-Proline and (c) Fe-L- Proline in 0.1M KCl solution at a Pt-button different amino acids and metal-amino acid systems.
  • Amino Acid Chemistry

    Amino Acid Chemistry

    Handout 4 Amino Acid and Protein Chemistry ANSC 619 PHYSIOLOGICAL CHEMISTRY OF LIVESTOCK SPECIES Amino Acid Chemistry I. Chemistry of amino acids A. General amino acid structure + HN3- 1. All amino acids are carboxylic acids, i.e., they have a –COOH group at the #1 carbon. 2. All amino acids contain an amino group at the #2 carbon (may amino acids have a second amino group). 3. All amino acids are zwitterions – they contain both positive and negative charges at physiological pH. II. Essential and nonessential amino acids A. Nonessential amino acids: can make the carbon skeleton 1. From glycolysis. 2. From the TCA cycle. B. Nonessential if it can be made from an essential amino acid. 1. Amino acid "sparing". 2. May still be essential under some conditions. C. Essential amino acids 1. Branched chain amino acids (isoleucine, leucine and valine) 2. Lysine 3. Methionine 4. Phenyalanine 5. Threonine 6. Tryptophan 1 Handout 4 Amino Acid and Protein Chemistry D. Essential during rapid growth or for optimal health 1. Arginine 2. Histidine E. Nonessential amino acids 1. Alanine (from pyruvate) 2. Aspartate, asparagine (from oxaloacetate) 3. Cysteine (from serine and methionine) 4. Glutamate, glutamine (from α-ketoglutarate) 5. Glycine (from serine) 6. Proline (from glutamate) 7. Serine (from 3-phosphoglycerate) 8. Tyrosine (from phenylalanine) E. Nonessential and not required for protein synthesis 1. Hydroxyproline (made postranslationally from proline) 2. Hydroxylysine (made postranslationally from lysine) III. Acidic, basic, polar, and hydrophobic amino acids A. Acidic amino acids: amino acids that can donate a hydrogen ion (proton) and thereby decrease pH in an aqueous solution 1.
  • Nucleotides and Nucleic Acids

    Nucleotides and Nucleic Acids

    Nucleotides and Nucleic Acids Energy Currency in Metabolic Transactions Essential Chemical Links in Response of Cells to Hormones and Extracellular Stimuli Nucleotides Structural Component Some Enzyme Cofactors and Metabolic Intermediate Constituents of Nucleic Acids: DNA & RNA Basics about Nucleotides 1. Term Gene: A segment of a DNA molecule that contains the information required for the synthesis of a functional biological product, whether protein or RNA, is referred to as a gene. Nucleotides: Nucleotides have three characteristic components: (1) a nitrogenous (nitrogen-containing) base, (2) a pentose, and (3) a phosphate. The molecule without the phosphate groups is called a nucleoside. Oligonucleotide: A short nucleic acid is referred to as an oligonucleotide, usually contains 50 or fewer nucleotides. Polynucleotide: Polymers containing more than 50 nucleotides is usually referred to as polynucleotide. General structure of nucleotide, including a phosphate group, a pentose and a base unit (either Purine or Pyrimidine). Major purine and Pyrimidine bases of nucleic acid The roles of RNA and DNA DNA: a) Biological Information Storage, b) Biological Information Transmission RNA: a) Structural components of ribosomes and carry out the synthesis of proteins (Ribosomal RNAs: rRNA); b) Intermediaries, carry genetic information from gene to ribosomes (Messenger RNAs: mRNA); c) Adapter molecules that translate the information in mRNA to proteins (Transfer RNAs: tRNA); and a variety of RNAs with other special functions. 1 Both DNA and RNA contain two major purine bases, adenine (A) and guanine (G), and two major pyrimidines. In both DNA and RNA, one of the Pyrimidine is cytosine (C), but the second major pyrimidine is thymine (T) in DNA and uracil (U) in RNA.
  • Oxidation of Pristanic Acid in Fibroblasts and Its Application to the Diagnosis of Peroxisomal ␤-Oxidation Defects

    Oxidation of Pristanic Acid in Fibroblasts and Its Application to the Diagnosis of Peroxisomal ␤-Oxidation Defects

    Oxidation of Pristanic Acid in Fibroblasts and Its Application to the Diagnosis of Peroxisomal ␤-Oxidation Defects Barbara C. Paton,* Peter C. Sharp,* Denis I. Crane,‡ and Alf Poulos* *Department of Chemical Pathology, Women’s and Children’s Hospital, North Adelaide, South Australia 5006; and ‡Faculty of Science and Technology, Griffith University, Nathan, Queensland 4111, Australia Abstract phology of peroxisomes in their tissues is accompanied by a series of biochemical abnormalities. Subsequent complemen- Pristanic acid oxidation measurements proved a reliable tation analyses have indicated that the three clinical pheno- tool for assessing complementation in fused heterokaryons types can arise from defects in a single gene (1, 2). In addition, from patients with peroxisomal biogenesis defects. We, in spite of all of these patients sharing the same series of bio- therefore, used this method to determine the complementa- chemical abnormalities, it is now clear that the peroxisomal tion groups of patients with isolated defects in peroxisomal biogenesis disorders, as a group, can result from defects in any ␤-oxidation. The rate of oxidation of pristanic acid was re- of at least 10 genes (2, 3). Recent evidence suggests that three duced in affected cell lines from all of the families with in- of these complementation groups have defects in the import of herited defects in peroxisomal ␤-oxidation, thus excluding peroxisomal matrix proteins via both of the known targeting the possibility of a defective acyl CoA oxidase. Complemen- mechanisms (peroxisomal targeting signals [PTS]1 1 and 2), tation analyses indicated that all of the patients belonged to but that for one of the complementation groups the defect is the same complementation group, which corresponded to restricted to proteins targeted via PTS1 (4).
  • Nucleotide Base Coding and Am1ino Acid Replacemients in Proteins* by Emil L

    Nucleotide Base Coding and Am1ino Acid Replacemients in Proteins* by Emil L

    VOL. 48, 1962 BIOCHEMISTRY: E. L. SAIITH 677 18 Britten, R. J., and R. B. Roberts, Science, 131, 32 (1960). '9 Crestfield, A. M., K. C. Smith, and F. WV. Allen, J. Biol. Chem., 216, 185 (1955). 20 Gamow, G., Nature, 173, 318 (1954). 21 Brenner, S., these PROCEEDINGS, 43, 687 (1957). 22 Nirenberg, M. WV., J. H. Matthaei, and 0. WV. Jones, unpublished data. 23 Crick, F. H. C., L. Barnett, S. Brenner, and R. J. Watts-Tobin, Nature, 192, 1227 (1961). 24 Levene, P. A., and R. S. Tipson, J. Biol. Ch-nn., 111, 313 (1935). 25 Gierer, A., and K. W. Mundry, Nature, 182, 1437 (1958). 2' Tsugita, A., and H. Fraenkel-Conrat, J. Mllot. Biol., in press. 27 Tsugita, A., and H. Fraenkel-Conrat, personal communication. 28 Wittmann, H. G., Naturwissenschaften, 48, 729 (1961). 29 Freese, E., in Structure and Function of Genetic Elements, Brookhaven Symposia in Biology, no. 12 (1959), p. 63. NUCLEOTIDE BASE CODING AND AM1INO ACID REPLACEMIENTS IN PROTEINS* BY EMIL L. SMITHt LABORATORY FOR STUDY OF HEREDITARY AND METABOLIC DISORDERS AND THE DEPARTMENTS OF BIOLOGICAL CHEMISTRY AND MEDICINE, UNIVERSITY OF UTAH COLLEGE OF MEDICINE Communicated by Severo Ochoa, February 14, 1962 The problem of which bases of messenger or template RNA' specify the coding of amino acids in proteins has been largely elucidated by the use of synthetic polyri- bonucleotides.2-7 For these triplet nucleotide compositions (Table 1), it is of in- terest to examine some of the presently known cases of amino acid substitutions in polypeptides or proteins of known structure.
  • LIPID METABOLISM-3 Regulation of Fatty Acid Oxidation

    LIPID METABOLISM-3 Regulation of Fatty Acid Oxidation

    LIPID METABOLISM-3 Regulation of Fatty Acid Oxidation 1. Carnitine shuttle by which fatty acyl groups are carried from cytosolic fatty acyl–CoA into the mitochondrial matrix is rate limiting for fatty acid oxidation and is an important point of regulation. 2. Malonyl-CoA, the first intermediate in the cytosolic biosynthesis of long-chain fatty acids from acetyl-CoA increases in concentration whenever the body is well supplied with carbohydrate; excess glucose that cannot be oxidized or stored as glycogen is converted in the cytosol into fatty acids for storage as triacylglycerol. The inhibition of CAT I by malonyl-CoA ensures that the oxidation of fatty acids is inhibited whenever the liver is actively making triacylglycerols from excess glucose. Two of the enzymes of β-oxidation are also regulated by metabolites that signal energy sufficiency. 3. When the [NADH]/[NAD+] ratio is high, β- hydroxyacyl-CoA dehydrogenase is inhibited; 4. When acetyl-CoA concentration is high, thiolase is inhibited. 5. During periods of vigorous muscle contraction or during fasting, the fall in [ATP] and the rise in [AMP] activate the AMP-activated protein kinase (AMPK). AMPK phosphorylates several target enzymes, including acetyl-CoA carboxylase (ACC), which catalyzes malonyl-CoA synthesis. Phosphorylation and inhibition of ACC lowers the concentration of malonyl-CoA, relieving the inhibition of acyl–carnitine transport into mitochondria and allowing oxidation to replenish the supply of ATP. MITOCHONDRIA PEROXISOME Respiratory chain Respiratory chain Out of organel To citric acid cycle Out of organel Comparison of mitochondrial and peroxisomal beta-oxidation • Another important difference between mitochondrial and peroxisomal oxidation in mammals is in the specificity for fatty acyl– CoAs; the peroxisomal system is much more active on very-long-chain fatty acids such as hexacosanoic acid (26:0) and on branched chain fatty acids such as phytanic acid and pristanic acid.